Online Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 385 - Biomarkers, Endpoint Validation and Other Topics
Type: Contributed
Date/Time: Thursday, August 12, 2021 : 12:00 PM to 1:50 PM
Sponsor: Biopharmaceutical Section
Abstract #318400
Title: Using a Piecewise Model to Account for Treatment Gaps When Evaluating Continuous Outcomes
Author(s): Xiaolei Zhou*
Companies: RTI Health Solutions
Keywords: Treatment gap; Piecewise model; Time-dependent covariate
Abstract:

After the completion of an initial clinical trial, sponsors may choose to or be required by regulatory agencies to conduct an extension study in which patients will continue to receive the study treatment. Combining data from the two studies will provide a treatment duration longer than individual studies that can be used to evaluate long-term treatment effect and safety. In practice, there are often treatment gaps between the initial clinical study and the extension study. The treatment gaps can have a negative impact on study outcomes, and the duration of treatment gaps often varies by individuals. To account for the treatment gap and the duration of the gap, we developed a piecewise mixed model that allows a growth rate during the treatment gap to be different from the growth rate when individuals are treated; it also allows individuals to have their own treatment gap start and end days. This model was applied to a pooled database of clinical trials with extension studies. The model provides flexibility to fit the data with various treatment gap durations and to adjust their impact on treatment effect.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2021 program